Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation and Natural History of Children With Cancer and AIDS

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00001424
First received: November 3, 1999
Last updated: March 3, 2008
Last verified: October 1999

November 3, 1999
March 3, 2008
November 1994
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00001424 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluation and Natural History of Children With Cancer and AIDS
Evaluation and Natural History of Children With Cancer and AIDS

Patients enrolled in this study will not receive investigational therapy. Any treatments rendered will be standard and based on appropriate medical care. Should a patient become eligible for an experimental therapy protocol, the normal process of enrollment and informed consent will be followed.

This protocol will enable the Pediatric Branch to follow selected children with cancer or HIV infection who are not immediately eligible for protocol enrollment but who are likely, within the next year, to become candidates for protocol entry. It will also enable the Pediatric Branch to follow children who present with either clinical findings that constitute important educational experiences for the NCI trainees or who have unique or unusual medical problems that are likely to benefit from the research expertise of the NCI.

Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
  • Acquired Immunodeficiency Syndrome
  • Cancer
  • HIV Infections
  • Leukemia
  • Lymphoma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
110
August 2000
Not Provided

Children with cancer (or a precancer syndrome) or HIV infection, between the age(s) of 3 months to 30 years, who are evaluated by the Pediatric Branch and are found to be not immediately eligible for an ongoing protocol but are likely to become a candidate for a future protocol.

Children with cancer (or a precancer syndrome) or HIV infection, who present with disease manifestations of special interest to Pediatric Branch investigators, because they are likely to shed light on disease.

Patients who, when evaluated by the Branch, are determined to likely never become eligible for a Pediatric Branch protocol are not eligible for this protocol.

No patients younger than 3 months of age or older than 30 years of age are eligible for this protocol.

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00001424
950025, 95-C-0025
Not Provided
Not Provided
National Cancer Institute (NCI)
Not Provided
Not Provided
National Institutes of Health Clinical Center (CC)
October 1999

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP